Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features

被引:23
|
作者
Rosso Schons, Karen Regina [1 ]
Costa Beber, Andre Avelino [2 ]
Beck, Maristela de Oliveira [2 ]
Monticielo, Odirlei Andre [3 ]
机构
[1] Univ Passo Fundo, Passo Fundo, RS, Brazil
[2] Univ Fed Santa Maria, BR-97119900 Santa Maria, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
关键词
Dermatology; Nails; Psoriasis; QUALITY-OF-LIFE; SEVERITY; MODERATE; DISEASE; VALIDATION; MANAGEMENT; ARTHRITIS; THERAPY; BURDEN; SCALE;
D O I
10.1590/abd1806-4841.20153736
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Psoriasis is a disease of worldwide distribution with a prevalence of 1 to 3%. Nail psoriasis is estimated in 50% of patients with psoriasis, and in the presence of joint involvement, it can reach 80%. OBJECTIVE: To study the nail changes - and their clinical implications - presented by patients with psoriasis vulgaris under surveillance in a university hospital from the south of Brazil. METHODS: This cross-sectional study evaluated 65 adult patients from January 2012 to March 2013. Cutaneous severity was assessed according to the Psoriasis Area and Severity Index (PASI). The Nail Psoriasis Severity Index (NAPSI) was used to evaluate patient's nails. The diagnosis of psoriatic arthritis was established according to the Classification Criteria for Psoriatic Arthritis (CASPAR). RESULTS: The prevalence of NP was 46.1%. These patients had a median [interquartilic range (IQR)] NAPSI of 1 (015). A total of 63.3% of patients reported aesthetic discomfort or functional impairment related to their nails. Onycholysis was the most common feature (80%). When compared with patients without nail involvement, patients with NP had lower mean age at psoriasis onset [21 (18-41) vs. 43 (30-56) years, p=0,001]; longer disease duration [15.5 (10-24) vs. 6 (2-12) years, p=0.001]; higher PASI [9.2 (5-17) vs. 3.7 (2-10), p=0.044], higher frequency of psoriatic arthritis (43.3 vs. 3.7, p=0.002) and more often reported family history of psoriasis (40% vs. 7.4%, p=0.011). CONCLUSION: Onycholysis was the most frequent finding and most patients feel uncomfortable with the psoriatic nail changes that they experience.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 50 条
  • [41] Clinical efficacy of bromocriptine and the influence of serum prolactin levels on disease severity in patients with chronic plaque-type psoriasis
    AbouKhedr, Nouran Abdelaziz
    Eid, Amira Abulfotooh
    ALEXANDRIA JOURNAL OF MEDICINE, 2013, 49 (04) : 385 - 389
  • [42] Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis
    Martin Ezquerra, Gemma
    Sanchez Regana, Manuel
    Umbert Millet, Pau
    ACTA DERMATO-VENEREOLOGICA, 2007, 87 (05) : 449 - 450
  • [43] Targeted UV-B Phototherapy for Plaque-type Psoriasis
    Asawanonda, P
    Chingchai, A
    Torranin, P
    ARCHIVES OF DERMATOLOGY, 2005, 141 (12) : 1542 - 1546
  • [45] Activation of the renin-angiotensin axis in moderate to severe plaque-type psoriasis patients
    Ortins-Pina, Ana
    Gil, Angela
    Matos, Andreia
    Teixeira, Ana Isabel
    Filipe, Paulo
    Bicho, Manuel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB29 - AB29
  • [46] Treatment of plaque-type psoriasis with cream-PUVA therapy
    Steinmeyer, K
    Grundmann-Kollmann, M
    Podda, M
    Kaufmann, R
    HAUTARZT, 2001, 52 (10): : 885 - 887
  • [47] Intralesional cyclosporine versus dithranol in the treatment of plaque-type psoriasis
    PetronicRosic, VM
    Marinkovic, JM
    Cvijetic, OB
    EUROPEAN JOURNAL OF DERMATOLOGY, 1997, 7 (07) : 492 - 496
  • [48] Non-pustular primary annular plaque-type psoriasis
    Aromolo, Italo F.
    Rocca, Lorenzo
    Benaglia, Chiara
    Simeoli, Domenico
    Perego, Gabriele
    Cattaneo, Angelo
    Carrera, Carlo G.
    Marzano, Angelo, V
    Maronese, Carlo A.
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2025, 160 (01) : 79 - 80
  • [49] Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasis
    Vidal, D.
    Salleras, M.
    Romani, J.
    Ribera, M.
    Gallardo, F.
    Vinas, M.
    Xifra, A.
    Garcia-Navarro, X.
    Bordas, X.
    Ferran, M.
    Carrascosa, J. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : E131 - E132
  • [50] Infliximab monotherapy is a remittive treatment for plaque-type psoriasis.
    Gottlieb, AB
    Chaudhari, U
    Mulcahy, LD
    Li, S
    Dooley, LT
    Baker, DG
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S161 - S161